216 related articles for article (PubMed ID: 22496410)
1. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
Everaert I; Taes Y; De Heer E; Baelde H; Zutinic A; Yard B; Sauerhöfer S; Vanhee L; Delanghe J; Aldini G; Derave W
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1537-44. PubMed ID: 22496410
[TBL] [Abstract][Full Text] [Related]
2. Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans.
Everaert I; Mooyaart A; Baguet A; Zutinic A; Baelde H; Achten E; Taes Y; De Heer E; Derave W
Amino Acids; 2011 Apr; 40(4):1221-9. PubMed ID: 20865290
[TBL] [Abstract][Full Text] [Related]
3. A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.
Riedl E; Koeppel H; Brinkkoetter P; Sternik P; Steinbeisser H; Sauerhoefer S; Janssen B; van der Woude FJ; Yard BA
Diabetes; 2007 Sep; 56(9):2410-3. PubMed ID: 17601991
[TBL] [Abstract][Full Text] [Related]
4. Does low serum carnosinase activity favor high-intensity exercise capacity?
Baguet A; Everaert I; Yard B; Peters V; Zschocke J; Zutinic A; De Heer E; Podgórski T; Domaszewska K; Derave W
J Appl Physiol (1985); 2014 Mar; 116(5):553-9. PubMed ID: 24408989
[TBL] [Abstract][Full Text] [Related]
5. [Carnosine, carnosinase and kidney diseases].
Kiliś-Pstrusińska K
Postepy Hig Med Dosw (Online); 2012 Apr; 66():215-21. PubMed ID: 22706107
[TBL] [Abstract][Full Text] [Related]
6. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
Janssen B; Hohenadel D; Brinkkoetter P; Peters V; Rind N; Fischer C; Rychlik I; Cerna M; Romzova M; de Heer E; Baelde H; Bakker SJ; Zirie M; Rondeau E; Mathieson P; Saleem MA; Meyer J; Köppel H; Sauerhoefer S; Bartram CR; Nawroth P; Hammes HP; Yard BA; Zschocke J; van der Woude FJ
Diabetes; 2005 Aug; 54(8):2320-7. PubMed ID: 16046297
[TBL] [Abstract][Full Text] [Related]
7. Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.
Stegen S; Sigal RJ; Kenny GP; Khandwala F; Yard B; De Heer E; Baelde H; Peersman W; Derave W
Am J Physiol Endocrinol Metab; 2015 Oct; 309(7):E663-9. PubMed ID: 26389600
[TBL] [Abstract][Full Text] [Related]
8. Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
Peters V; Zschocke J; Schmitt CP
J Inherit Metab Dis; 2018 Jan; 41(1):39-47. PubMed ID: 29027595
[TBL] [Abstract][Full Text] [Related]
9. Profiling histidine dipeptides in plasma and urine after ingesting beef, chicken or chicken broth in humans.
Yeum KJ; Orioli M; Regazzoni L; Carini M; Rasmussen H; Russell RM; Aldini G
Amino Acids; 2010 Mar; 38(3):847-58. PubMed ID: 19381778
[TBL] [Abstract][Full Text] [Related]
10. Carnosine and Kidney Diseases: What We Currently Know?
Kilis-Pstrusinska K
Curr Med Chem; 2020; 27(11):1764-1781. PubMed ID: 31362685
[TBL] [Abstract][Full Text] [Related]
11. Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration.
Peters V; Jansen EE; Jakobs C; Riedl E; Janssen B; Yard BA; Wedel J; Hoffmann GF; Zschocke J; Gotthardt D; Fischer C; Köppel H
Clin Chim Acta; 2011 Jan; 412(3-4):263-7. PubMed ID: 20971102
[TBL] [Abstract][Full Text] [Related]
12. Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
Peters V; Schmitt CP; Zschocke J; Gross ML; Brismar K; Forsberg E
Amino Acids; 2012 Jun; 42(6):2411-6. PubMed ID: 21833769
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity.
Qiu J; Hauske SJ; Zhang S; Rodriguez-Niño A; Albrecht T; Pastene DO; van den Born J; van Goor H; Ruf S; Kohlmann M; Teufel M; Krämer BK; Hammes HP; Peters V; Yard BA; Kannt A
Amino Acids; 2019 Jan; 51(1):7-16. PubMed ID: 29922921
[TBL] [Abstract][Full Text] [Related]
14. Carnosine and Diabetic Nephropathy.
Peters V; Yard B; Schmitt CP
Curr Med Chem; 2020; 27(11):1801-1812. PubMed ID: 30914013
[TBL] [Abstract][Full Text] [Related]
15. Carnosinase deficiency: a new variant with high residual activity.
Fleisher LD; Rassin DK; Wisniewski K; Salwen HR
Pediatr Res; 1980 Apr; 14(4 Pt 1):269-71. PubMed ID: 7375183
[TBL] [Abstract][Full Text] [Related]
16. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
Freedman BI; Hicks PJ; Sale MM; Pierson ED; Langefeld CD; Rich SS; Xu J; McDonough C; Janssen B; Yard BA; van der Woude FJ; Bowden DW
Nephrol Dial Transplant; 2007 Apr; 22(4):1131-5. PubMed ID: 17205963
[TBL] [Abstract][Full Text] [Related]
17. Association of CTG repeat polymorphism in carnosine dipeptidase 1 (
Yadav AK; Sinha N; Kumar V; Bhansali A; Dutta P; Jha V
Indian J Med Res; 2016 Jul; 144(1):32-37. PubMed ID: 27834323
[TBL] [Abstract][Full Text] [Related]
18. A Global Cndp1-Knock-Out Selectively Increases Renal Carnosine and Anserine Concentrations in an Age- and Gender-Specific Manner in Mice.
Weigand T; Colbatzky F; Pfeffer T; Garbade SF; Klingbeil K; Colbatzky F; Becker M; Zemva J; Bulkescher R; Schürfeld R; Thiel C; Volk N; Reuss D; Hoffmann GF; Freichel M; Hecker M; Poth T; Fleming T; Poschet G; Schmitt CP; Peters V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664451
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic carnosine metabolism in the human kidney.
Peters V; Klessens CQ; Baelde HJ; Singler B; Veraar KA; Zutinic A; Drozak J; Zschocke J; Schmitt CP; de Heer E
Amino Acids; 2015 Dec; 47(12):2541-50. PubMed ID: 26206726
[TBL] [Abstract][Full Text] [Related]
20. Serum Carnosinase-1 and Albuminuria Rather than the
Rodriguez-Niño A; Hauske SJ; Herold A; Qiu J; van den Born J; Bakker SJL; Krämer BK; Yard BA
J Diabetes Res; 2019; 2019():6850628. PubMed ID: 31950064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
